Match each clinical presentation of infective endocarditis with the most appropriate empiric or targeted antimicrobial regimen.
- A 55-year-old man with native valve endocarditis caused by methicillin-susceptible Staphylococcus aureus (MSSA) and no known drug allergies.Intravenous cefazolin or intravenous nafcillin
- A 68-year-old woman with suspected prosthetic valve endocarditis, presenting with fever and a new murmur 3 months after a surgical aortic valve replacement.Intravenous vancomycin, intravenous gentamicin, and oral rifampin
- A 72-year-old man with native valve endocarditis caused by Enterococcus faecalis and a history of severe chronic kidney disease.Intravenous ampicillin plus intravenous ceftriaxone
- A 45-year-old woman with subacute native valve endocarditis caused by Streptococcus gallolyticus that is highly susceptible to penicillin.Intravenous aqueous crystalline penicillin G or intravenous ceftriaxone (monotherapy)
Answer
The correct matches are: Native valve MSSA endocarditis pairs with IV cefazolin or nafcillin; early prosthetic valve endocarditis pairs with IV vancomycin, gentamicin, and rifampin; Enterococcal endocarditis in a patient with chronic kidney disease pairs with IV ampicillin plus ceftriaxone; and highly penicillin-susceptible Streptococcus gallolyticus endocarditis pairs with IV penicillin G or ceftriaxone monotherapy.
Each pathogen and clinical scenario in infective endocarditis requires a specific, guideline-directed antimicrobial regimen to ensure bactericidal activity, penetrate biofilms on prostheses, and minimize systemic toxicity.
Step-by-Step Solution
Key Concept
Appropriate antimicrobial selection for infective endocarditis depends heavily on the causative pathogen, the presence of prosthetic material (requiring biofilm penetration), and patient-specific comorbidities such as underlying renal dysfunction.